Final Safety Results from ATHENA–MONO (Gog-3020/Engot-ov45), a Randomized, Placebo-Controlled, Double-Blind, Phase 3 Trial Evaluating Rucaparib Monotherapy As Maintenance Treatment in Patients with Newly Diagnosed Ovarian Cancer.
Journal of Clinical Oncology（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined